Correlation of parasite load determined by quantitative PCR to clinical outcome in a heart transplant patient with disseminated toxoplasmosis

Journal of Clinical Microbiology

Volumn 48, Issue 7, 2010, Pages 2541-2545

  Patrat Delon, Solène ^a   Gangneux, Jean Pierre ^b   Lavoué, Sylvain ^a   Lelong, Bernard ^a   Guiguen, Claude ^b   Le Tulzo, Yves ^a   Robert Gangneux, Florence ^b  

^a RENNES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; ANTIINFECTIVE AGENT; PROTOZOAL DNA; PROTOZOON ANTIBODY;

ACUTE KIDNEY FAILURE; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; BLOOD EXAMINATION; CASE REPORT; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID EXAMINATION; CONTROLLED STUDY; DISSEMINATED TOXOPLASMOSIS; DRUG WITHDRAWAL; FEMALE; GRAFT RECIPIENT; HEART GRAFT; HUMAN; INFECTION PREVENTION; LEUKOPENIA; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE STUDY; SEROPREVALENCE; THROMBOCYTOPENIA; TOXOPLASMOSIS; TREATMENT DURATION; ANIMAL; GENETICS; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; ISOLATION AND PURIFICATION; MIDDLE AGED; PARASITOLOGY; PROCEDURES; TOXOPLASMA;

PNEUMOCYSTIS JIROVECII; TOXOPLASMA;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIBODIES, PROTOZOAN; DNA, PROTOZOAN; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; MALE; MICE; MIDDLE AGED; POLYMERASE CHAIN REACTION; TOXOPLASMA; TOXOPLASMOSIS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 77954428737     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00252-10     Document Type: Article

References (34)

1. Ajzenberg, D., H. Yera, P. Marty, L. Paris, F. Dalle, J. Menotti, D. Aubert, J. Franck, M. H. Bessières, D. Quinio, H. Pelloux, L. Delhaes, N. Desbois, P. Thulliez, F. Robert-Gangneux, C. Kauffmann-Lacroix, S. Pujol, M. Rabodonirina, M. E. Bougnoux, B. Cuisenier, C. Duhamel, T. H. Duong, D. Filisetti, P. Flori, F. Gay-Andrieu, F. Pratlong, G. Nevez, A. Totet, B. Carme, H. Bonnabau, M. L. Dardé, and I. Villena. 2009. Genotype of 88 Toxoplasma gondii isolates associated with toxoplasmosis in immunocompromised patients and correlation with clinical findings. J. Infect. Dis. 199:1155-1167.
2. Baden, L. R., J. T. Katz, L. Franck, S. Tsang, M. Hall, R. H. Rubin, and J. Jarcho. 2003. Successful toxoplasmosis prophylaxis after orthotopic cardiac transplantation with trimethoprim-sulfamethoxazole. Transplantation 75:339-343. (Pubitemid 36222959)
3. Baran, D. A., M. M. Alwarshetty, S. Alvi, L. H. Arroyo, S. Lubitz, S. Pinney, A. L. Gass, and M. J. Zucker. 2006. Is toxoplasmosis prophylaxis necessary in cardiac transplantation? Long-term follow-up at two transplant centers. J. Heart Lung Transplant. 25:1380-1382.
4. Barcán, L. A., M. L. Dallurzo, L. O. Clara, A. Valledor, S. Macias, E. Zorkin, S. Gerona, and B. Livellara. 2002. Toxoplasma gondii pneumonia in liver transplantation: survival after a severe case of reactivation. Transpl. Infect. Dis. 4:93-96.
5. Béraud, G., S. Pierre-François, A. Foltzer, S. Abel, B. Liautaud, D. Smadja, and A. Cabié. 2009. Cotrimoxazole for treatment of cerebral toxoplasmosis: an observational cohort study during 1994-2006. Am. J. Trop. Med. Hyg. 80:583-587.
6. Botterel, F., P. Ichai, C. Feray, P. Bouree, F. Saliba, R. Tur Raspa, D. Samuel, and S. Romand. 2002. Disseminated toxoplasmosis, resulting from infection of allograft, after orthotopic liver transplantation: usefulness of quantitative PCR. J. Clin. Microbiol. 40:1648-1650.
7. Bretagne, S., J. M. Costa, F. Foulet, L. Jabot-Lestang, F. Baud-Camus, and C. Cordonnier. 2000. Prospective study of toxoplasma reactivation by polymerase chain reaction in allogeneic stem-cell transplant recipients. Transpl. Infect. Dis. 2:127-132.
8. Castagnini, M., S. Bernazzali, C. Ginanneschi, B. Marchi, M. Maccherini, C. Tsioulpas, and P. Tanganelli. 2007. Fatal disseminated toxoplasmosis in a cardiac transplantation with seropositive match for Toxoplasma: should prophylaxis be extended? Transpl. Immunol. 18:193-197.
9. Delhaes, L., J.-C. Mraz, E. Fréalle, I. Durand-Joly, L. Magro, D. Ajzenberg, M.-L. Dardé, E. Dei-Cas, and I. Yakoub-Agha. 13 July 2009. Severe pulmonary toxoplasmosis after allo-SCT in two patients: from Toxoplasma genotyping to clinical management. Bone Marrow Transplant. doi:10.1038/ bmt.2009.167.
10. Derouin, F., A. Devergie, P. Auber, E. Gluckman, B. Beauvais, Y. J. F. Garin, and M. Lariviere. 1992. Toxoplasmosis in bone marrow-transplant recipients: report of seven cases and review. Clin. Infect. Dis. 15:267-270.
11. Derouin, F., and H. Pelloux. 2008. Prevention of toxoplasmosis in transplant patients. Clin. Microbiol. Infect. 14:1089-1101.
12. Foot, A. B., Y. J. Garin, P. Ribaud, A. Devergie, F. Derouin, and E. Gluckman. 1994. Prophylaxis of toxoplasmosis infection with pyrimethamine/ sulfadoxine (Fansidar) in bone marrow transplant recipients. Bone Marrow Transplant. 14:241-245. (Pubitemid 24262547)
13. Fricker-Hidalgo, H., J. P. Brion, M. Durand, O. Chavanon, M. P. Brenier-Pinchart, and H. Pelloux. 2005. Disseminated toxoplasmosis with pulmonary involvement after heart transplantation. Transpl. Infect. Dis. 7:38-40.
14. Fricker-Hidalgo, H., C. E. Bulabois, M. P. Brenier-Pinchart, R. Hamidfar, F. Garban, J. P. Brion, J. F. Timsit, J. Y. Cahn, and H. Pelloux. 2009. Diagnosis of toxoplasmosis after allogeneic stem cell transplantation: results of DNA detection and serological techniques. Clin. Infect. Dis. 48:e9-e15.
15. Fung, H. B., and H. L. Kirschenbaum. 1996. Treatment regimens for patients with toxoplasmic encephalitis. Clin. Ther. 18:1037-1056.
16. Gallino, A., M. Maggiorini, W. Kiowski, X. Martin, W. Wunderli, J. Schneider, M. Turina, and F. Follath. 1996. Toxoplasmosis in heart transplant recipients. Eur. J. Clin. Microbiol. Infect. Dis. 15:389-393.
17. Goebel, W. S., J. H. Conway, P. Faught, S. Vakili, and P. R. Haut. 2007. Disseminated toxoplasmosis resulting in graft failure in a cord blood stem cell transplant recipient. Pediatr. Blood Cancer 48:222-226.
18. Gourishankar, S., K. Doucette, J. Fenton, D. Purych, K. Kowalewska-Grochowska, and J. Preiksaitis. 2008. The use of donor and recipients screening for Toxoplasma in the era of universal trimethoprim sulfamethoxazole prophylaxis. Transplantation 85:980-985.
19. Luft, B. J., Y. Naot, F. G. Araujo, E. B. Stinson, and J. S. Remington. 1983. Primary and reactivated Toxoplasma infection in patients with cardiac transplants. Clinical spectrum and problems in diagnosis in a defined population. Ann. Intern. Med. 99:27-31.
20. Martino, R., S. Bretagne, H. Einsele, J. Maertens, A. J. Ullmann, R. Parody, U. Schumacher, C. Pautas, K. Theunissen, C. Schindel, C. Muňoz, N. Margall, and C. Cordonnier. 2005. Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation. Clin. Infect. Dis. 40:67-78.
21. Menotti, J., G. Vilela, S. Romand, Y. J. F. Garin, L. Ades, E. Gluckman, F. Derouin, and P. Ribaud. 2003. Comparison of PCR-enzyme-linked immunosorbent assay and real-time PCR assay for diagnosis of an unusual case of cerebral toxoplasmosis in a stem cell transplant recipient. J. Clin. Microbiol. 41:5313-5316.
22. Michaels, M. G., E. R. Wald, F. J. Fricker, P. J. del Nido, and J. Armitage. 1992. Toxoplasmosis in pediatric recipients of heart transplants. Clin. Infect. Dis. 14:847-851.
23. Montoya, J. G., L. F. Giraldo, B. Efron, E. B. Stinson, P. Gamberg, S. Hunt, N. Giannetti, J. Miller, and J. S. Remington. 2001. Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center. Clin. Infect. Dis. 33:629-640.
24. Muñoz, P., J. Arencibia, C. Rodríguez, M. Rivera, J. Palomo, J. Yañez, and E. Bouza. 2003. Trimethoprim-sulfamethoxazole as toxoplasmosis prophylaxis for heart transplant recipients. Clin. Infect. Dis. 36:932-933.
25. Orr, K. E., F. K. Gould, G. Short, J. H. Dark, C. J. Hilton, P. A. Corris, and R. Freeman. 1994. Outcome of Toxoplasma gondii mismatches in heart transplant recipients over a period of 8 years. J. Infect. 29:249-253.
26. Podzamczer, D., J. M. Miró, E. Ferrer, J. M. Gatell, J. M. Ramón, E. Ribera, G. Sirera, A. Cruceta, H. Knobel, P. Domingo, R. Polo, M. Leyes, J. Cosin, M. C. Fariñas, J. Arrizabalaga, J. Martínez-Lacasa, and F. Gudiol. 2000. Thrice-weekly sulfadiazine- pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study Group. Eur. J. Clin. Microbiol. Infect. Dis. 19:89-95.
27. Robert-Gangneux, F., C. Amrein, V. Lavarde, F. Botterel, and J. Dupouy-Camet. 2000. Neosynthesized IgG detected by Western blotting in Toxoplasma-seropositive heart or lung transplant recipients. Transpl. Int. 13: 448-452.
28. Robert-Gangneux, F., P. Dupretz, C. Yvenou, D. Quinio, P. Poulain, C. Guiguen, and J. P. Gangneux. 2010. Clinical relevance of placenta examination for the diagnosis of congenital toxoplasmosis. Pediatr. Infect. Dis. J. 29:33-38.
29. Rogers, N. M., C. A. Peh, R. Faull, M. Pannell, J. Cooper, and G. R. Russ. 2008. Transmission of toxoplasmosis in two renal allograft recipients receiving an organ from the same donor. Transpl. Infect. Dis. 10:71-74.
30. Schürmann, D., F. Bergmann, H. Albrecht, J. Padberg, T. Wünsche, T. Grünewald, M. Schürmann, M. Grobusch, M. Vallée, B. Ruf, and N. Suttorp. 2002. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection. Eur. J. Clin. Microbiol. Infect. Dis. 21:353-361.
31. Soave, R. 2001. Prophylaxis strategies for solid-organ transplantation. Clin. Infect. Dis. 33:S26-S31.
32. Speirs, G. E., M. Hakim, R. Y. Calne, and T. G. Wreghitt. 1988. Relative risk of donor-transmitted Toxoplasma gondii infection in heart, liver and kidney transplant recipients. Clin. Transplant. 2:257-260.
33. Wreghitt, T. G., M. Hakim, J. J. Gray, A. H. Balfour, P. G. Stovin, S. Stewart, J. Scott, T. A. English, and J. Wallwork. 1989. Toxoplasmosis in heart and heart and lung transplant recipients. J. Clin. Pathol. 42:194-199.
34. Wulf, M. W. H., R. van Crevel, R. Portier, C. G. ter Meulen, W. J. G. Melchers, A. van der Ven, and J. M. D. Galama. 2005. Toxoplasmosis after renal transplantation: implications of a missed diagnosis. J. Clin. Microbiol. 43:3544-3547.